Feedback on Decentralized Clinical Trials

Written by Barbara Brown

July 19, 2023

The FDA is seeking feedback on its document entitled Decentralized Clinical Trials for Drugs, Biological Products, and Devices Guidance for Industry, Investigators, and Other Stakeholders – this draft Guidance is available at https://www.regulations.gov/document/FDA-2022-D-2870-0002. The deadline to submit comments is August 1.

You May Also Like…

Happy Pride Month!

Happy Pride Month!

At N2, we warmly embrace and stand with individuals of all sexual orientations, as well as those with any gender...